Minor addition on Pfizer with additional 20 shares bought for 30,53 USD per share. Broker had black friday campaign so reinvested some USD dividends without transactions fees. Pfizer has dropped significantly as Covid boost is gone and some people apparently wouldn’t mind seeing Pfizer and others being hit with legal issues. Still, drop seems a bit drastic given the size of the company and impact on whole sector. I will not likely add much on the position though since I consider this sector as one that is best approached with a basket of stocks. If I would be truly able to analyse their backlog, I would probably work in big pharma myself.
Maintenance purchase and dividend re-investment once again in the form of 10 Kesko Oyj shares bought for 17,29 EUR per share. Tiny steps and nothing special here. Kesko share recovered already a bit so won’t make any big moves for now. Valuation is still very reasonable given the overall quality of the company and international – well Scandinavian – potential.